Health DG: Will take four months to evaluate Pfizer trial data

PUTRAJAYA: It will take up to four months for the National Pharmaceutical Regulatory Agency (NPRA) to evaluate the clinical trial data provided by pharmaceutical giant Pfizer on the Covid-19 vaccine it has developed.

Health director-general Tan Sri Dr Noor Hisham Abdullah said the NPRA received a formal application from Pfizer on Dec 15 to have its Covid-19 vaccine registered in Malaysia.